Institution
Tohoku University
Recent research
- Society & EconomicsOpen access
Abstract Aim Attention‐deficit/hyperactivity disorder (ADHD) is a recognized related factor for gambling problems. Although ADHD frequently co‐occurs with autism spectrum disorder (ASD) and adverse childhood experiences (ACEs), the interaction of these factors on gambling has not...
- Society & EconomicsOpen access
Rural community revitalization through disaster tourism in Japan
The Great East Japan Earthquake and Tsunami (GEJET) in 2011 precipitated a profound socio-economic crisis in the Tohoku region, exacerbating pre-existing depopulation and aging trends. In response, the Japanese government’s “New Tohoku” initiative has prioritized rural community...
- Health & MedicineOpen access
Mandibular condylar fractures constitute a significant proportion of maxillofacial trauma and are associated with functional impairment and increased healthcare utilization. However, factors associated with the duration of hospital stay remain insufficiently understood, particula...
- Health & MedicineOpen access
Preservation of the peritoneum is essential for the safe continuation of peritoneal dialysis (PD). Although PD fluid with low glucose degradation products (low GDP) are widely used, objective macroscopic assessment of the peritoneum during ongoing PD remains limited. We therefore...
- Engineering & TechnologyOpen access
Abstract Understanding liquid behavior on the surface of rapidly rotating turbine blades is essential for clarifying drain formation in wet-steam turbines. However, direct experimental visualization of droplet impact and subsequent liquid transport under the combined conditions o...
- Health & MedicineOpen access
Cancer cells maintain chronically elevated levels of reactive oxygen species (ROS) while relying on robust antioxidant programs to preserve redox homeostasis and viability. Although therapeutic strategies that disrupt this balance to induce lethal oxidative stress and ferroptosis...
- Health & MedicineOpen access
ABSTRACT Background Cabozantinib (CABO) is currently an essential drug for first‐line and sequential therapy in the treatment of advanced renal cell carcinoma (RCC). Predicting its therapeutic efficacy will enable efficient drug selection and improve the prognosis of patients. We...